Hedge Fund - Acuta Capital Partners
Celldex Therapeutics Inc. (CLDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $37.73 |
| 2 | 2024 - Q1 (2024-03-31) | $4,574,730 | 2.97% | 109,000 | $41.06 |
| 3 | 2023 - Q4 (2023-12-31) | $2,752,404 | 1.54% | 69,400 | $29.41 |
| 4 | 2023 - Q3 (2023-09-30) | $3,366,824 | 2.25% | 122,341 | $31.35 |
| 5 | 2023 - Q2 (2023-06-30) | $4,151,098 | 2.81% | 122,343 | $33.70 |
| 6 | 2023 - Q1 (2023-03-31) | $4,371,570 | 3.22% | 121,500 | $43.15 |
| 7 | 2022 - Q4 (2022-12-31) | $5,125,550 | 3.15% | 115,000 | $35.70 |
| 8 | 2022 - Q3 (2022-09-30) | $7,511,000 | 3.23% | 267,195 | $30.66 |
| 9 | 2022 - Q2 (2022-06-30) | $7,204,000 | 4.01% | 267,195 | $29.04 |
| 10 | 2022 - Q1 (2022-03-31) | $10,998,000 | 5.13% | 322,898 | $31.97 |
| 11 | 2021 - Q4 (2021-12-31) | $13,141,000 | 5.52% | 340,098 | $43.58 |
| 12 | 2021 - Q3 (2021-09-30) | $18,222,000 | 6.42% | 337,500 | $46.92 |
| 13 | 2021 - Q2 (2021-06-30) | $33,019,000 | 13.19% | 987,406 | $27.45 |
| 14 | 2021 - Q1 (2021-03-31) | $20,961,000 | 7.55% | 1,017,524 | $22.96 |
| 15 | 2020 - Q4 (2020-12-31) | $28,514,000 | 7.75% | 1,627,500 | $18.00 |
| 16 | 2020 - Q3 (2020-09-30) | $22,912,000 | 6.22% | 1,545,000 | $11.71 |
| 17 | 2020 - Q2 (2020-06-30) | $13,000,000 | 3.75% | 1,000,000 | $4.43 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:15.0000 on 2019-02-11